Mechanism of lymphocytic choriomeningitis virus entry into cells.
about
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogsCharacterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virusO-Mannosylation and human diseaseHepatitis C Virus Entry Depends on Clathrin-Mediated EndocytosisLearning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the NucleusStructure of a Zinc-binding Domain in the Junin Virus Envelope GlycoproteinUnique small molecule entry inhibitors of hemorrhagic fever arenaviruses.Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymersNovel approaches in anti-arenaviral drug developmentAn antibody directed against the fusion peptide of Junin virus envelope glycoprotein GPC inhibits pH-induced membrane fusion.Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections.The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transportRING finger Z protein of lymphocytic choriomeningitis virus (LCMV) inhibits transcription and RNA replication of an LCMV S-segment minigenome.LCMV glycosylation modulates viral fitness and cell tropism.Pathogenesis of arenavirus hemorrhagic fevers.The curious case of arenavirus entry, and its inhibition.Multifunctional nature of the arenavirus RING finger protein Z.A systems biology starter kit for arenaviruses.Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junín virus envelope glycoprotein complex.Cell entry by human pathogenic arenaviruses.Selective inhibitor of endosomal trafficking pathways exploited by multiple toxins and viruses.Exploring kinase inhibitors as therapies for human arenavirus infections.Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.Timed appearance of lymphocytic choriomeningitis virus after gastric inoculation of miceSelf-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon functionOld World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.Lassa virus.A novel zinc-binding domain is essential for formation of the functional Junín virus envelope glycoprotein complex.Signal peptide requirements for lymphocytic choriomeningitis virus glycoprotein C maturation and virus infectivity.Emerging virus diseases: can we ever expect the unexpected?Cell entry of Lassa virus induces tyrosine phosphorylation of dystroglycan.Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.Binding of Lassa virus perturbs extracellular matrix-induced signal transduction via dystroglycan.The signal peptide of the Junín arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex.Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitroInhibition of the type I interferon antiviral response during arenavirus infection.Host cell factors as antiviral targets in arenavirus infection.Structure-function relationship of the mammarenavirus envelope glycoprotein.
P2860
Q24524801-C6BAA9D5-0E53-4DC8-9B78-B7CE876065CAQ24541217-2355C9BF-F92B-4047-8414-D49B5AA8F9CDQ27014986-D9A7D047-601F-4A58-94ED-BB4CE05182D9Q27473290-3EA4FE33-F021-420E-B95B-CAA01285B965Q27488284-9EF1FC8B-5914-43B3-8C83-51F6A257237BQ27665779-7F9002A2-03D7-40D6-B7E5-14CE691E2944Q33334027-1827FCAB-50AE-46B9-9D35-9161911B5342Q33652265-D918E3AA-8760-4080-B8D6-6E4178996097Q33779739-F370565D-8EF8-4CE1-87D0-B266E90FBADCQ33877501-9729DB68-1D84-4F83-8082-72ECEC436EBDQ33887328-A72B0326-AC9B-41B5-9F0D-F72ADBCB8E02Q33948025-8BE78404-7579-47AC-B8CF-DD1DBBA37499Q34023003-7094CB16-F45A-4CA3-BFBA-AA655E0D9759Q34089004-EAE74D48-5612-440E-A3C4-B70BF32C09BDQ34544878-92524015-2141-4FB7-A3CB-65BC519906E4Q34625899-3BF4D010-9EA4-4F00-BE32-8C224CE49D0BQ34636037-D663FFA0-4229-4522-B8A9-E511BFE8EEB4Q34645925-379C8BAA-B9DE-40FC-BE47-C0279CC00F36Q34647510-3F6E6870-9A40-49A3-9AF5-1755A219B373Q34648056-6EE22EB5-80CC-4EC4-92EA-D732DDF85A58Q34734128-5267D34F-B68A-439A-A7C9-B73ED2444E97Q35031738-EC83B713-30BC-47AA-AC18-B6C4712E40F1Q35635901-5D967883-E100-4476-9059-0ADEA1048E65Q35652155-A04423D0-728C-428D-92C0-D6A8865D90B3Q35751585-D18D9089-3DAA-4000-AE21-0F9E73E7C11DQ35763835-1D3866FF-79F4-4C88-A4F2-10C449E96D78Q35826274-67A3F967-AC02-481B-AC51-75573F582F14Q35857739-70B15D15-2C6B-47EF-B115-FF402A8E9377Q35919691-6ED5BCF1-4ED3-45D1-9E5E-7838C56BDEF7Q36315194-FC8562BE-03C5-4FE5-9D72-22CFC46FFAF1Q36315430-E13955FA-BAAF-4BAD-A27E-69F089F5085DQ36779688-F7C68529-B2A5-44E5-80A0-1C3D03F6AB97Q37247060-CA448335-D49B-47CC-8EAC-0899444B086FQ37394607-8ACE0353-357F-4C8F-BFF0-57EB13ADF48BQ37406952-45B879F7-8DFC-41FF-9398-B0EEDDC4F661Q37511518-B908F553-1274-45C3-A91E-FFB30F669EFEQ37547599-74FC3882-171A-4421-A078-B4CAE491D33CQ37945195-FECC6E59-97EC-4ECA-8EDC-9122218D87EAQ38061425-E1C4EFCA-7A6D-4D81-9D23-140628C937FEQ38937488-0563B8BB-5E0B-4DE5-B4FB-E47F794AA34D
P2860
Mechanism of lymphocytic choriomeningitis virus entry into cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Mechanism of lymphocytic choriomeningitis virus entry into cells.
@en
type
label
Mechanism of lymphocytic choriomeningitis virus entry into cells.
@en
prefLabel
Mechanism of lymphocytic choriomeningitis virus entry into cells.
@en
P356
P1433
P1476
Mechanism of lymphocytic choriomeningitis virus entry into cells
@en
P2093
Oldstone MB
P356
10.1006/VIRO.1994.1001
P407
P577
1994-01-01T00:00:00Z